This review will discuss recently FDA-approved agents for advanced prostate cancer and those under investigation in phase III trials.
Joshua M. Ruch, MD
Advertisement
Articles by Joshua M. Ruch, MD
Advertisement
Latest Updated Articles
- Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Published: May 15th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
3
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
4
FDA Approves Revumenib in R/R NPM1-Mutant AML
5
